Description |
prothymosin alpha |
RAN, member RAS oncogene family |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
|
Interacting Genes |
44 interacting genes:
CASP3
CASP7
CCNA2
CCNB1
CDK1
CDK2
CDK4
CREBBP
EP300
ESR1
GSK3A
H1-1
H2AC14
H2BC21
H2BC8
H3-4
H3C14
H4C1
H4C14
HDAC1
HDAC2
HSPA1A
IL7R
KEAP1
KPNA2
KPNB1
NCOR1
NUP62
NUPR1
NUTF2
PCNA
PHB2
PTPN2
RAN
RCC1
SET
SIN3A
STAT3
TERF1
TERF2
TERF2IP
TERT
VIPR1
ZDHHC17
|
60 interacting genes:
ABL1
ADRB2
AR
ASAP2
BCAR1
BIRC5
BMPR1B
CEP126
CSE1L
DNAH5
DUX4
EP300
GADD45G
GIT1
IPO11
IPO13
IPO5
IPO7
KPNA2
KPNB1
MBP
MSL1
NEK9
NR3C1
NSMF
NUP153
NUP50
NUTF2
NXF1
NXT1
PAK4
PARP10
POLE
PTMA
RANBP1
RANBP10
RANBP2
RANBP3
RANBP9
RANGAP1
RANGRF
RCC1
RGPD5
RPL7
SMAD1
SMAD2
SMARCB1
SMURF2
SNUPN
SPAG8
SSRP1
SUMO2
TGFBR1
TNPO1
TNPO2
XPO1
XPO4
XPO5
XPO7
XPOT
|
Entrez ID |
5757 |
5901 |
HPRD ID |
01778 |
03109 |
Ensembl ID |
ENSG00000187514
|
ENSG00000132341
|
Uniprot IDs |
P06454
Q53S24
|
B4DV51
P62826
|
PDB IDs |
2L9I
2MNQ
|
1I2M
1IBR
1K5D
1K5G
1QBK
1RRP
2MMC
2MMG
2N1B
3CH5
3EA5
3GJ0
3GJ3
3GJ4
3GJ5
3GJ6
3GJ7
3GJ8
3GJX
3NBY
3NBZ
3NC0
3NC1
3ZJY
4C0Q
4GMX
4GPT
4HAT
4HAU
4HAV
4HAW
4HAX
4HAY
4HAZ
4HB0
4HB2
4HB3
4HB4
4OL0
4WVF
5CIQ
5CIT
5CIW
5CJ2
5CLL
5CLQ
5DH9
5DHA
5DHF
5DI9
5DIF
5DIS
5DLQ
5FYQ
5JLJ
5UWH
5UWI
5UWJ
5UWO
5UWP
5UWQ
5UWR
5UWS
5UWT
5UWU
5UWW
5YRO
5YST
5YSU
5YTB
5ZPU
6A38
6A3A
6A3B
6A3C
6A3E
6CIT
6KFT
6Q82
6Q84
6TVO
6X2M
6X2O
6X2P
6X2R
6X2S
6X2U
6X2V
6X2W
6X2X
6X2Y
6XJP
6XJR
6XJS
6XJT
6XJU
7L5E
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|